Recombinant Human Granulocyte Colony-Stimulating Market

List of Tables
Table 1. Recombinant Human Granulocyte Colony-Stimulating CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Recombinant Human Granulocyte Colony-Stimulating Market Trends
Table 3. Recombinant Human Granulocyte Colony-Stimulating Market Drivers
Table 4. Recombinant Human Granulocyte Colony-Stimulating Market Challenges
Table 5. Recombinant Human Granulocyte Colony-Stimulating Market Restraints
Table 6. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Recombinant Human Granulocyte Colony-Stimulating Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Recombinant Human Granulocyte Colony-Stimulating Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Recombinant Human Granulocyte Colony-Stimulating Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturer, 2017-2022
Table 13. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturer, (KG), 2017-2022
Table 14. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Manufacturer, 2017-2022
Table 15. Global Recombinant Human Granulocyte Colony-Stimulating Price by Manufacturer (2017-2022) & (USD/g)
Table 16. Global Recombinant Human Granulocyte Colony-Stimulating Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Recombinant Human Granulocyte Colony-Stimulating by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Granulocyte Colony-Stimulating as of 2021)
Table 18. Top Players of Recombinant Human Granulocyte Colony-Stimulating in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Type
Table 20. Date of International Manufacturers Enter into Recombinant Human Granulocyte Colony-Stimulating Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Recombinant Human Granulocyte Colony-Stimulating Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Recombinant Human Granulocyte Colony-Stimulating Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Recombinant Human Granulocyte Colony-Stimulating Sales by Players, (KG), 2020, 2021 & 2022
Table 26. United States Recombinant Human Granulocyte Colony-Stimulating Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Region (2017-2022) & (KG)
Table 29. Global Recombinant Human Granulocyte Colony-Stimulating Sales in Volume Forecast by Region (2023-2028) & (KG)
Table 30. Global Recombinant Human Granulocyte Colony-Stimulating Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Recombinant Human Granulocyte Colony-Stimulating Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Country (2017-2028) & (KG)
Table 33. North America Recombinant Human Granulocyte Colony-Stimulating Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Region (2017-2028) & (KG)
Table 35. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Country (2017-2028) & (KG)
Table 37. Europe Recombinant Human Granulocyte Colony-Stimulating Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Country (2017-2028) & (KG)
Table 39. Latin Americaa Recombinant Human Granulocyte Colony-Stimulating Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Country (2017-2028) & (KG)
Table 41. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Amgen Corporation Information
Table 43. Amgen Description and Business Overview
Table 44. Amgen Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 45. Amgen Recombinant Human Granulocyte Colony-Stimulating Product
Table 46. Amgen Recent Development
Table 47. Qilu Pharmaceutical Corporation Information
Table 48. Qilu Pharmaceutical Description and Business Overview
Table 49. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 50. Qilu Pharmaceutical Product
Table 51. Qilu Pharmaceutical Recent Development
Table 52. Shijiazhuang Pharmaceutical Corporation Information
Table 53. Shijiazhuang Pharmaceutical Description and Business Overview
Table 54. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 55. Shijiazhuang Pharmaceutical Product
Table 56. Shijiazhuang Pharmaceutical Recent Development
Table 57. Kyowa Hakko Kirin Corporation Information
Table 58. Kyowa Hakko Kirin Description and Business Overview
Table 59. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 60. Kyowa Hakko Kirin Product
Table 61. Kyowa Hakko Kirin Recent Development
Table 62. Gensci Corporation Information
Table 63. Gensci Description and Business Overview
Table 64. Gensci Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 65. Gensci Product
Table 66. Gensci Recent Development
Table 67. Amoytop Biotech Corporation Information
Table 68. Amoytop Biotech Description and Business Overview
Table 69. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 70. Amoytop Biotech Product
Table 71. Amoytop Biotech Recent Development
Table 72. Hangzhou Jiuyuan Corporation Information
Table 73. Hangzhou Jiuyuan Description and Business Overview
Table 74. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 75. Hangzhou Jiuyuan Product
Table 76. Hangzhou Jiuyuan Recent Development
Table 77. Huaxin Corporation Information
Table 78. Huaxin Description and Business Overview
Table 79. Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 80. Huaxin Product
Table 81. Huaxin Recent Development
Table 82. Triprime Corporation Information
Table 83. Triprime Description and Business Overview
Table 84. Triprime Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 85. Triprime Product
Table 86. Triprime Recent Development
Table 87. Sinovac Corporation Information
Table 88. Sinovac Description and Business Overview
Table 89. Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 90. Sinovac Product
Table 91. Sinovac Recent Development
Table 92. Zhaoke Corporation Information
Table 93. Zhaoke Description and Business Overview
Table 94. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 95. Zhaoke Product
Table 96. Zhaoke Recent Development
Table 97. Kawin Corporation Information
Table 98. Kawin Description and Business Overview
Table 99. Kawin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 100. Kawin Product
Table 101. Kawin Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Recombinant Human Granulocyte Colony-Stimulating Customers List
Table 105. Recombinant Human Granulocyte Colony-Stimulating Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Granulocyte Colony-Stimulating Product Picture
Figure 2. Global Recombinant Human Granulocyte Colony-Stimulating Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Recombinant Human Granulocyte Colony-Stimulating Market Size 2017-2028 (US$ Million)
Figure 4. Global Recombinant Human Granulocyte Colony-Stimulating Sales 2017-2028 (KG)
Figure 5. United States Recombinant Human Granulocyte Colony-Stimulating Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Recombinant Human Granulocyte Colony-Stimulating Market Size 2017-2028 (US$ Million)
Figure 7. United States Recombinant Human Granulocyte Colony-Stimulating Sales 2017-2028 (KG)
Figure 8. United States Recombinant Human Granulocyte Colony-Stimulating Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Recombinant Human Granulocyte Colony-Stimulating Market Share in Global, in Volume (KG) 2017-2028
Figure 10. Recombinant Human Granulocyte Colony-Stimulating Report Years Considered
Figure 11. Product Picture of Lenograstim (Granocyte)
Figure 12. Product Picture of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
Figure 13. Product Picture of Others
Figure 14. Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2022 & 2028
Figure 15. Global Recombinant Human Granulocyte Colony-Stimulating Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2028) & (KG)
Figure 18. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2017-2028) & (USD/g)
Figure 20. United States Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2022 & 2028
Figure 21. United States Recombinant Human Granulocyte Colony-Stimulating Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Recombinant Human Granulocyte Colony-Stimulating Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2028) & (KG)
Figure 24. United States Recombinant Human Granulocyte Colony-Stimulating Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Recombinant Human Granulocyte Colony-Stimulating Price by Type (2017-2028) & (USD/g)
Figure 26. Product Picture of Chemotherapy Induced Neutropenia
Figure 27. Product Picture of Before Blood Donation
Figure 28. Product Picture of Stem Cell Transplants
Figure 29. Product Picture of Others
Figure 30. Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2022 & 2028
Figure 31. Global Recombinant Human Granulocyte Colony-Stimulating Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2028) & (KG)
Figure 34. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2017-2028) & (USD/g)
Figure 36. United States Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2022 & 2028
Figure 37. United States Recombinant Human Granulocyte Colony-Stimulating Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Recombinant Human Granulocyte Colony-Stimulating Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2028) & (KG)
Figure 40. United States Recombinant Human Granulocyte Colony-Stimulating Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Recombinant Human Granulocyte Colony-Stimulating Price by Application (2017-2028) & (USD/g)
Figure 42. North America Recombinant Human Granulocyte Colony-Stimulating Sales in Volume Growth Rate 2017-2028 (KG)
Figure 43. North America Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Recombinant Human Granulocyte Colony-Stimulating Sales in Volume Growth Rate 2017-2028 (KG)
Figure 47. Europe Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales in Volume Growth Rate 2017-2028 (KG)
Figure 54. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales in Volume Growth Rate 2017-2028 (KG)
Figure 66. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales in Volume Growth Rate 2017-2028 (KG)
Figure 71. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Recombinant Human Granulocyte Colony-Stimulating Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Recombinant Human Granulocyte Colony-Stimulating Value Chain
Figure 76. Recombinant Human Granulocyte Colony-Stimulating Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed